USE OF DIRECT THROMBIN INHIBITORS FOR TREATING NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES IN SPECIAL PATIENT GROUPS: WOMEN, DIABETICS, THE ELDERLY, AND CHRONIC RENAL INSUFFICIENCY

This complimentary newsletter provides a targeted review of the results of the ACUITY trial with particular emphasis on the high risk populations - women, elderly, diabetics, and patients with chronic renal insufficiency. In addition, he describes the findings of ACUITY in relation to therapy "switch", when patients were initially treated with heparins prior to randomization. Emergency physicians are increasingly becoming exposed to a greater variety of therapies for patients with acute coronary syndrome. It is our hope to provide you, the practicing clinician, with the educational tools to continue to give outstanding care to your patients.

2007 DTI Special pops.png